Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus
about
Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesisInhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol)Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complementRole of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupusAnalysis of the interactions between properdin, the third component of complement (C3), and its physiological activation productsInhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranesClearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.Dynamics of interaction between complement-fixing antibody/dsDNA immune complexes and erythrocytes. In vitro studies and potential general applications to clinical immune complex testing.Primate erythrocyte-immune complex-clearing mechanism.In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzeesLinking complement and anti-dsDNA antibodies in the pathogenesis of systemic lupus erythematosusLate onset Alzheimer's disease genetics implicates microglial pathways in disease risk.Genetic regulation of a structural polymorphism of human C3b receptor.Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serumComplement factor H deficiency accelerates development of lupus nephritis.Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus.Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.Abnormality of glycophorin-alpha on paroxysmal nocturnal hemoglobinuria erythrocytes.Complement depletion accelerates the clearance of immune complexes from the circulation of primates.Biosynthesis of the human C3b/C4b receptor during differentiation of the HL-60 cell line. Identification and characterization of a precursor molecule.Nomination of a candidate susceptibility gene in sarcoidosis: the complement receptor 1 gene.Complement and systemic lupus erythematosus.Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytesStimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface.Regulation of circulating immune complexes by complement receptor type 1 on erythrocytes in chronic viral liver diseases.Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies.Diminished expression of complement regulatory proteins on peripheral blood cells from systemic lupus erythematosus patients.Effect of human serum and some of its components on neutrophil adherence and migration across an epithelium.Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.Experimental IgA nephropathy induced by oral immunizationPolymorphism of the human C3b/C4b receptor. Identification of a third allele and analysis of receptor phenotypes in families and patients with systemic lupus erythematosusControl of the function of substrate-bound C4b-C3b by the complement receptor Cr1.Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis.Human genes for three complement components that regulate the activation of C3 are tightly linked.Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function-associated antigen 3 (LFA-3)Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids
P2860
Q24294595-41105654-5B23-4142-AA00-194265A1B27EQ24527312-E2FB6DA2-73FA-4101-9DC5-7982C075827EQ24529520-7742D64F-690B-40DA-A1E3-E554B33C7A43Q24805723-0E9820EE-5C72-41D9-97D5-B1846DD62313Q28610971-8DA53218-171D-4E35-BA80-0BA76FD5DD20Q28610983-E54CC014-BA57-44F7-878A-B1AD0C548416Q30306247-EDE96E7E-2991-414A-BD84-81243F10014BQ30449404-2EFD5AA0-A71B-4B46-BCC9-0962BA051B5AQ30449428-2D0E1C48-AC88-4D5E-8827-F927C708FAC5Q30449835-FB6A2D17-E09B-4700-AA53-853798A05D5FQ33599086-D408273F-045A-490B-953B-B8AC62B504A3Q33733863-DD1FB80A-6C46-4356-A59E-DC51C2983921Q33822131-CAC16194-04F2-42DE-BDA8-28C2F5741902Q34249094-49A12DAE-ACD7-42C9-9528-CF3C812FD72EQ34534879-F43EF734-DB6A-4C29-A7A1-A5ADC14E5B9EQ34542184-D08E99DA-F311-478E-9F0B-E92FB4426513Q34542324-6B6C002C-CB3A-4431-AB04-A4838E5F7EE3Q34558907-AC0A2470-38CA-487B-B643-A4B4E982C769Q34608150-D26355D5-D227-4FA3-90E1-4BE66726E00DQ34617128-E23FF2BE-BEF8-4698-A5B7-06CBA3C0FE9CQ34619233-B0216409-3E91-43C1-8DE2-71151D59F758Q34714540-6ADED2FF-5E46-411C-BCAD-3F49EA5C2D79Q34731255-052F0518-6010-4F45-AEFB-E2C54046B3E0Q35575831-A8E4DB21-A626-4D17-B156-6BDAFB159ACFQ35577517-EF072409-5B09-4604-9D74-E856D0ED4639Q35595003-CD3B9490-A2EB-498B-83E2-93FCFED8BAF6Q35609298-3550E71C-C01D-4346-9ACA-305D3924B9B6Q36065619-4DEB85E8-BBFC-4FBE-AE8F-F89A2FEB9606Q36214906-1883E575-EFBD-4CDC-A113-64EBA9CCB16FQ36347257-54A95517-D8FB-4F51-A16D-806020935557Q36347412-4521E7AD-A510-4FA7-A8D5-D9D820CD9D59Q36348542-CEACF04F-7D40-423D-8F86-A89ECFC93623Q36348868-8B25FB3C-BE9D-45F8-8CEC-6408A2CA6502Q36348883-8C411BC9-2ACB-4488-BBDD-C4C53C7807E2Q36349022-A14A9A7C-7173-4233-A5C7-763FC05E7AF4Q36349693-2CABC542-32F1-4987-A510-B4325FE9C540Q36349954-FAF2CCEB-37C9-4D56-8048-4D54E2A1AE18Q36350414-50AA177A-A5D4-4803-9270-DA4CCDEDDBF9Q36352467-D8ED6727-7B4A-4324-933A-16C5B62DBD33Q36352511-1D5C6F84-6EF5-46E7-A9F2-F202FF13EC12
P2860
Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus
description
1982 nî lūn-bûn
@nan
1982 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Complement receptor (CR1) defi ...... h systemic lupus erythematosus
@ast
Complement receptor (CR1) defi ...... h systemic lupus erythematosus
@en
Complement receptor (CR1) defi ...... h systemic lupus erythematosus
@nl
type
label
Complement receptor (CR1) defi ...... h systemic lupus erythematosus
@ast
Complement receptor (CR1) defi ...... h systemic lupus erythematosus
@en
Complement receptor (CR1) defi ...... h systemic lupus erythematosus
@nl
prefLabel
Complement receptor (CR1) defi ...... h systemic lupus erythematosus
@ast
Complement receptor (CR1) defi ...... h systemic lupus erythematosus
@en
Complement receptor (CR1) defi ...... h systemic lupus erythematosus
@nl
P2093
P2860
P356
P1476
Complement receptor (CR1) defi ...... h systemic lupus erythematosus
@en
P2093
P2860
P304
P356
10.1084/JEM.155.5.1427
P407
P577
1982-05-01T00:00:00Z